» Articles » PMID: 26431421

MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis

Abstract

Arteriogenesis, the growth of natural bypass arteries, is triggered by hemodynamic forces within vessels and requires a balanced inflammatory response, involving induction of the chemokine MCP-1 and recruitment of leukocytes. However, little is known how these processes are coordinated. The MAP-kinase-activated-proteinkinase-2 (MK2) is a critical regulator of inflammatory processes and might represent an important link between cytokine production and cell recruitment during postnatal arteriogenesis. Therefore, the present study investigated the functional role of MK2 during postnatal arteriogenesis. In a mouse model of hindlimb ischemia (HLI) MK2-deficiency (MK2KO) significantly impaired ischemic blood flow recovery and growth of collateral arteries as well as perivascular recruitment of mononuclear cells and macrophages. This was accompanied by induction of endothelial MCP-1 expression in wildtype (WT) but not in MK2KO collateral arteries. Following HLI, MK2 activation rapidly occured in the endothelium of growing WT arteries in vivo. In vitro, inflammatory cytokines and cyclic stretch activated MK2 in endothelial cells, which was required for stretch- and cytokine-induced release of MCP-1. In addition, a monocyte cell autonomous function of MK2 was uncovered potentially regulating MCP-1-dependent monocyte recruitment to vessels: MCP-1 stimulation of WT monocytes induced MK2 activation and monocyte migration in vitro. The latter was reduced in MK2KO monocytes, while in vivo MK2 was activated in monocytes recruited to collateral arteries. In conclusion, MK2 regulates postnatal arteriogenesis by controlling vascular recruitment of monocytes/macrophages in a dual manner: regulation of endothelial MCP-1 expression in response to hemodynamic and inflammatory forces as well as MCP-1 dependent monocyte migration.

Citing Articles

Cre toxicity in mouse models of cardiovascular physiology and disease.

Rashbrook V, Brash J, Ruhrberg C Nat Cardiovasc Res. 2023; 1:806-816.

PMID: 37692772 PMC: 7615056. DOI: 10.1038/s44161-022-00125-6.


Cross-species transcriptomic signatures predict response to MK2 inhibition in mouse models of chronic inflammation.

Suarez-Lopez L, Shui B, Brubaker D, Hill M, Bergendorf A, Changelian P iScience. 2021; 24(12):103406.

PMID: 34849469 PMC: 8609096. DOI: 10.1016/j.isci.2021.103406.


MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer.

Suarez-Lopez L, Kong Y, Sriram G, Patterson J, Rosenberg S, Morandell S Front Immunol. 2021; 11:607891.

PMID: 33708191 PMC: 7940202. DOI: 10.3389/fimmu.2020.607891.


Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia.

Beltran-Camacho L, Rojas-Torres M, Duran-Ruiz M Int J Mol Sci. 2021; 22(5).

PMID: 33652743 PMC: 7956816. DOI: 10.3390/ijms22052335.


Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia.

Beltran-Camacho L, Jimenez-Palomares M, Rojas-Torres M, Sanchez-Gomar I, Rosal-Vela A, Eslava-Alcon S Stem Cell Res Ther. 2020; 11(1):106.

PMID: 32143690 PMC: 7060566. DOI: 10.1186/s13287-020-01591-0.


References
1.
Chen Z, Rubin J, Tzima E . Role of PECAM-1 in arteriogenesis and specification of preexisting collaterals. Circ Res. 2010; 107(11):1355-63. PMC: 3244947. DOI: 10.1161/CIRCRESAHA.110.229955. View

2.
Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk H . MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol. 1999; 1(2):94-7. DOI: 10.1038/10061. View

3.
Cambien B, Pomeranz M, Millet M, Rossi B, Schmid-Alliana A . Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood. 2001; 97(2):359-66. DOI: 10.1182/blood.v97.2.359. View

4.
Bavendiek U, Libby P, Kilbride M, Reynolds R, Mackman N, Schonbeck U . Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J Biol Chem. 2002; 277(28):25032-9. DOI: 10.1074/jbc.M204003200. View

5.
Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M . Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol. 2002; 283(6):H2411-9. DOI: 10.1152/ajpheart.01098.2001. View